Literature DB >> 21196360

Protein kinase B/Akt regulation in diabetic kidney disease.

Mediha Heljić1, Derek P Brazil.   

Abstract

Many reviews have been written on protein kinase B/Akt focusing on its history dating back from the isolation of the Akt8 transforming murine leukemia virus by Staal in 1977, to the co-discovery of the Akt1 gene by the three groups in 1991 (reviewed in 7). There are currently over 22,000 publications in the PubMed database with "Akt" as a keyword - these publications describe a wealth of diverse data on the physiological functions of Akt isoforms. Many of these publications describe roles of Akt ranging from its requirement for cellular processes such as glucose uptake, cell survival and angiogenesis to roles in diseases such as cancer and ischaemia (22). This review will focus on the evidence for Akt signaling in different kidney cells during diabetes, or diabetic nephropathy (DN).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196360     DOI: 10.2741/s135

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  8 in total

1.  Astragaloside IV ameliorates renal injury in db/db mice.

Authors:  Huili Sun; Wenjing Wang; Pengxun Han; Mumin Shao; Gaofeng Song; Heng Du; Tiegang Yi; Shunmin Li
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

2.  The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy.

Authors:  Yanli Cheng; Xiaoyu Zhang; Fuzhe Ma; Weixia Sun; Wanning Wang; Jinyu Yu; Yue Shi; Lu Cai; Zhonggao Xu
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

3.  A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Authors:  Chunli Piao; Qi Zhang; Li Wang; Cheng Tang; Naiwen Zhang; Fengmei Lian; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

4.  Using Network Pharmacology to Explore the Mechanism of Peach Kernel-Safflower in the Treatment of Diabetic Nephropathy.

Authors:  Jingxue Han; Xinwei Wang; Jingyi Hou; Yu Liu; Peng Liu; Tingting Zhao
Journal:  Biomed Res Int       Date:  2021-02-01       Impact factor: 3.411

5.  Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats.

Authors:  Shaohua Li; Guangbiao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-17       Impact factor: 2.650

6.  Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology.

Authors:  Bingyu Du; Yanyan Yin; Yuqing Wang; Hui Fu; Helin Sun; Zhaodi Yue; Shaohong Yu; Zhongwen Zhang
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

7.  Low-dose radiation activates Akt and Nrf2 in the kidney of diabetic mice: a potential mechanism to prevent diabetic nephropathy.

Authors:  Xiao Xing; Chi Zhang; Minglong Shao; Qingyue Tong; Guirong Zhang; Cai Li; Jie Cheng; Shunzi Jin; Jisheng Ma; Guanjun Wang; Xiaokun Li; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2012-11-27       Impact factor: 6.543

8.  Fenofibrate attenuated glucose-induced mesangial cells proliferation and extracellular matrix synthesis via PI3K/AKT and ERK1/2.

Authors:  Rui Zeng; Yan Xiong; Fengming Zhu; Zufu Ma; Wenhui Liao; Yong He; JinSeng He; Wei Li; Juan Yang; Qian Lu; Gang Xu; Ying Yao
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.